Klerk CPW - Search Results

1

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.

de Jonge AV, Duetz C, Bruins WSC, Korst CLBM, Rentenaar R, Cosovic M, Eken M, Twickler I, Nijland M, van der Poel MWM, de Heer K, Klerk CPW, Strobbe L, Oosterveld M, Boersma R, Koene HR, Roemer MGM, van Werkhoven E, Chamuleau MED, Mutis T. de Jonge AV, et al. Among authors: klerk cpw. Blood Adv. 2024 Mar 12;8(5):1094-1104. doi: 10.1182/bloodadvances.2023011687. Blood Adv. 2024. PMID: 38191686 Free PMC article.

2

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience.

De Jong CN, Saes L, Klerk CPW, Van der Klift M, Cornelissen JJ, Broers AEC. De Jong CN, et al. Among authors: klerk cpw. PLoS One. 2017 Oct 26;12(10):e0187184. doi: 10.1371/journal.pone.0187184. eCollection 2017. PLoS One. 2017. PMID: 29073260 Free PMC article.

3

Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.

Libourel EJ, Klerk CPW, van Norden Y, de Maat MPM, Kruip MJ, Sonneveld P, Löwenberg B, Leebeek FWG. Libourel EJ, et al. Among authors: klerk cpw. Blood. 2016 Oct 6;128(14):1854-1861. doi: 10.1182/blood-2016-02-701094. Epub 2016 Jun 28. Blood. 2016. PMID: 27354723 Free article.

4

Graft-versus-leukemia in the bone marrow.

Klerk CP, Lam KH. Klerk CP, et al. Blood. 2014 Jan 23;123(4):470. doi: 10.1182/blood-2013-09-528950. Blood. 2014. PMID: 24605367 Free article. No abstract available.

5

Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver.

Klerk CP, Niers TM, Brüggemann LW, Smorenburg SM, Richel DJ, Spek CA, Van Noorden CJ. Klerk CP, et al. Thromb Res. 2010 Mar;125(3):235-8. doi: 10.1016/j.thromres.2009.03.005. Epub 2009 Apr 15. Thromb Res. 2010. PMID: 19371924 No abstract available.

6

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung.

Niers TM, Brüggemann LW, Klerk CP, Muller FJ, Buckle T, Reitsma PH, Richel DJ, Spek CA, Van Tellingen O, Van Noorden CJ. Niers TM, et al. Clin Exp Metastasis. 2009;26(3):171-8. doi: 10.1007/s10585-008-9227-6. Epub 2008 Dec 10. Clin Exp Metastasis. 2009. PMID: 19067186

7

Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals.

Klerk CP, Overmeer RM, Niers TM, Versteeg HH, Richel DJ, Buckle T, Van Noorden CJ, van Tellingen O. Klerk CP, et al. Biotechniques. 2007 Jul;43(1 Suppl):7-13, 30. doi: 10.2144/000112515. Biotechniques. 2007. PMID: 17936938 Free article. Review.

8

Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.

Niers TM, Di Nisio M, Klerk CP, Baarslag HJ, Büller HR, Biemond BJ. Niers TM, et al. J Thromb Haemost. 2007 Sep;5(9):1878-82. doi: 10.1111/j.1538-7836.2007.02660.x. J Thromb Haemost. 2007. PMID: 17723127 Free article. Clinical Trial.

9

Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation.

Klerk CP, Smorenburg SM, Spek CA, Van Noorden CJ. Klerk CP, et al. J Cell Mol Med. 2007 May-Jun;11(3):561-8. doi: 10.1111/j.1582-4934.2007.00046.x. J Cell Mol Med. 2007. PMID: 17635646 Free PMC article.

10

Mechanisms of heparin induced anti-cancer activity in experimental cancer models.

Niers TM, Klerk CP, DiNisio M, Van Noorden CJ, Büller HR, Reitsma PH, Richel DJ. Niers TM, et al. Crit Rev Oncol Hematol. 2007 Mar;61(3):195-207. doi: 10.1016/j.critrevonc.2006.07.007. Epub 2006 Oct 30. Crit Rev Oncol Hematol. 2007. PMID: 17074500 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page